Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lore Decoster

Showing results (51-60 of 71) with videos related to

Pageof 8
Sort By:
Clinical Colorectal Cancer|September 18, 2016
Relevance of Geriatric Assessment in Older Patients With Colorectal CancerLore Decoster, Leen Vanacker, Cindy Kenis, et al.
Journal of Geriatric Oncology|December 4, 2019
Real life safety and effectiveness of nivolumab in older patients with non-small cell lung cancer: Results from the Belgian compassionate use programSofie Joris, Thierry Pieters, Anne Sibille, et al.
European Journal of Endocrinology|July 23, 2019
Immune checkpoint inhibitors and type 1 diabetes mellitus: a case report and systematic reviewJeroen M K de Filette, Joeri J Pen, Lore Decoster, et al.
The Lancet. Oncology|February 6, 2025
Management of immune checkpoint inhibitor-associated toxicities in older adults with cancer: recommendations from the International Society of Geriatric Oncology (SIOG)Colm Mac Eochagain, Nina Rosa Neuendorff, Karolina Gente, et al.
Frontiers in Immunology|December 20, 2021
Transcutaneous Vagal Nerve Stimulation Alone or in Combination With Radiotherapy Stimulates Lung Tumor Infiltrating Lymphocytes But Fails to Suppress Tumor GrowthEva Reijmen, Sven De Mey, Helena Van Damme, et al.
Cancer Immunology, Immunotherapy : CII|July 2, 2024
A randomized phase II clinical trial of stereotactic body radiation therapy (SBRT) and systemic pembrolizumab with or without intratumoral avelumab/ipilimumab plus CD1c (BDCA-1)<sup>+</sup>/CD141 (BDCA-3)<sup>+</sup> myeloid dendritic cells in solid tumorsManon Vounckx, Jens Tijtgat, Latoya Stevens, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 20, 2023
Phase I Study of [<sup>68</sup>Ga]Ga-Anti-CD206-sdAb for PET/CT Assessment of Protumorigenic Macrophage Presence in Solid Tumors (MMR Phase I)Odrade Gondry, Catarina Xavier, Laurens Raes, et al.
Plos One|April 1, 2016
Prospective Evaluation of First-Line Erlotinib in Advanced Non-Small Cell Lung Cancer (NSCLC) Carrying an Activating EGFR Mutation: A Multicenter Academic Phase II Study in Caucasian Patients (FIELT)Jacques De Grève, Jan Van Meerbeeck, Johan F Vansteenkiste, et al.
International Journal of Cancer|November 21, 2019
The genomic landscape of nonsmall cell lung carcinoma in never smokersBram Boeckx, Rajendra B Shahi, Dominiek Smeets, et al.
BMC Geriatrics|November 19, 2022
Incidence of falls and fall-related injuries and their predictive factors in frail older persons with cancer: a multicenter studyCindy Kenis, Lore Decoster, Johan Flamaing, et al.
Pageof 8

Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
Clinical Colorectal Cancer|September 18, 2016
Relevance of Geriatric Assessment in Older Patients With Colorectal CancerLore Decoster, Leen Vanacker, Cindy Kenis, et al.
Journal of Geriatric Oncology|December 4, 2019
Real life safety and effectiveness of nivolumab in older patients with non-small cell lung cancer: Results from the Belgian compassionate use programSofie Joris, Thierry Pieters, Anne Sibille, et al.
European Journal of Endocrinology|July 23, 2019
Immune checkpoint inhibitors and type 1 diabetes mellitus: a case report and systematic reviewJeroen M K de Filette, Joeri J Pen, Lore Decoster, et al.
The Lancet. Oncology|February 6, 2025
Management of immune checkpoint inhibitor-associated toxicities in older adults with cancer: recommendations from the International Society of Geriatric Oncology (SIOG)Colm Mac Eochagain, Nina Rosa Neuendorff, Karolina Gente, et al.
Frontiers in Immunology|December 20, 2021
Transcutaneous Vagal Nerve Stimulation Alone or in Combination With Radiotherapy Stimulates Lung Tumor Infiltrating Lymphocytes But Fails to Suppress Tumor GrowthEva Reijmen, Sven De Mey, Helena Van Damme, et al.
Cancer Immunology, Immunotherapy : CII|July 2, 2024
A randomized phase II clinical trial of stereotactic body radiation therapy (SBRT) and systemic pembrolizumab with or without intratumoral avelumab/ipilimumab plus CD1c (BDCA-1)<sup>+</sup>/CD141 (BDCA-3)<sup>+</sup> myeloid dendritic cells in solid tumorsManon Vounckx, Jens Tijtgat, Latoya Stevens, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 20, 2023
Phase I Study of [<sup>68</sup>Ga]Ga-Anti-CD206-sdAb for PET/CT Assessment of Protumorigenic Macrophage Presence in Solid Tumors (MMR Phase I)Odrade Gondry, Catarina Xavier, Laurens Raes, et al.
Plos One|April 1, 2016
Prospective Evaluation of First-Line Erlotinib in Advanced Non-Small Cell Lung Cancer (NSCLC) Carrying an Activating EGFR Mutation: A Multicenter Academic Phase II Study in Caucasian Patients (FIELT)Jacques De Grève, Jan Van Meerbeeck, Johan F Vansteenkiste, et al.
International Journal of Cancer|November 21, 2019
The genomic landscape of nonsmall cell lung carcinoma in never smokersBram Boeckx, Rajendra B Shahi, Dominiek Smeets, et al.
BMC Geriatrics|November 19, 2022
Incidence of falls and fall-related injuries and their predictive factors in frail older persons with cancer: a multicenter studyCindy Kenis, Lore Decoster, Johan Flamaing, et al.
Pageof 8